Surgical Treatment of Refractory Open Angle Glaucoma

Status Completed

Clinical Trial Summary

The primary objective of this study is to evaluate the safety, efficacy, and performance of the Suprachoroidal Dissection Instrument in creating a fistula between Schlemm's canal and the suprachoroidal space in refractory, open angle glaucoma subjects.

Clinical Trial Description

The Suprachoroidal Dissection Instrument (SDI) is a manually operated surgical instrument designed for use within Schlemm's canal. The instrument can access Schlemm's canal through a small ab-externo dissection, allowing use in eyes with scarring due to previous surgery or trauma. ;

Study Design

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01212861
Study type	Interventional
Source	iScience Interventional Corporation
Contact
Status	Completed
Phase	N/A
Start date	August 2010
Completion date	May 2012

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03284853` - Safety and Efficacy Study of PG324 (Netarsudil/Latanoprost 0.02% / 0.005%) Ophthalmic Solution Compared to GANFORT® Ophthalmic Solution in Open Angle Glaucoma or Ocular Hypertension	Phase 3
Terminated	`NCT03611530` - CoQun Study - (COQUN): a Study to Evaluate the Effects of CoQun in Patients Affected by Open-angle Glaucoma	N/A
Not yet recruiting	`NCT06441643` - Next Generation Rocklatan	Phase 2
Not yet recruiting	`NCT02868502` - Different Glaucoma Treatments Effect on Intraocular Pressure Fluctuation With Postural Change in Eyes With Open-angle Glaucoma	N/A
Completed	`NCT02272569` - STARflo European Safety and Efficacy Study	N/A
Completed	`NCT02628223` - 180 Degree vs. 360 Degree Selective Laser Trabeculoplasty as Initial Therapy for Glaucoma	N/A
Completed	`NCT01936389` - A Prospective Study to Assess the Hypotensive Efficacy of Rho-Kinase Inhibitor AR-12286 Ophthalmic Solution 0.5% and 0.7% in Patients With Exfoliation Syndrome and Ocular Hypertension or Glaucoma	Phase 2
Completed	`NCT00941525` - Central Corneal Thickness and 24-hour Fluctuation of Intraocular Pressure	Phase 4
Completed	`NCT00539526` - Evaluation of Hyperemia With the Use of Ocular Prostaglandin Analogues	Phase 4
Completed	`NCT00121147` - Additivity Study: Additive Effect on Eye Pressure of Azopt and Alphagan P to Travatan	N/A
Active, not recruiting	`NCT05035394` - Swedish Microinvasive Glaucoma Surgery Study (SMIGS)	N/A
Completed	`NCT03450629` - Evaluation of Safety and Efficacy of PDP-716	Phase 3
Active, not recruiting	`NCT06061718` - Travoprost Intraocular Implant in Conjunction With Cataract Surgery	Phase 3
Recruiting	`NCT05241938` - PSLT Compared to Prostaglandin Analogue Eye Drops	N/A
Completed	`NCT01342406` - Effects of Selective Laser Trabeculoplasty on Aqueous Humor Dynamics
Completed	`NCT02250612` - SYL040012, Treatment for Open Angle Glaucoma	Phase 2
Completed	`NCT01937312` - Effect of SIMBRINZA® Suspension as an Added Therapy to a Prostaglandin Analogue	Phase 4
Terminated	`NCT01983579` - TF (SENSIMED Triggerfish) in Intraocular Anti-VEGF (Vascular Endothelial Growth Factor) Injection	Phase 4
Completed	`NCT01937299` - Effect of SIMBRINZA® Suspension as an Added Therapy to TRAVATAN Z®	Phase 4
Completed	`NCT01229982` - A Study Evaluating the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open-Angle Glaucoma	Phase 2